• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

夏季奥运会项目与女运动员:澳大利亚和新西兰与法国在反兴奋剂检测样本及检出违禁物质方面的比较

Summer Olympic sports and female athletes: comparison of anti-doping collections and prohibited substances detected in Australia and New Zealand vs. France.

作者信息

Buisson Corinne, Brooker Lance, Goebel Catrin, Morrow Ryan, Chakrabarty Rima, Speers Naomi, Molina Adeline, Ericsson Magnus, Collomp Katia

机构信息

LADF, French Anti-Doping Laboratory, Université Paris-Saclay, Orsay, France.

ASDTL, Australian Sports Drug Testing Laboratory, National Measurement Institute, Sydney, NSW, Australia.

出版信息

Front Sports Act Living. 2023 Sep 8;5:1213735. doi: 10.3389/fspor.2023.1213735. eCollection 2023.

DOI:10.3389/fspor.2023.1213735
PMID:37745202
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10515209/
Abstract

Like any athlete, female athletes may be tempted to use prohibited substances during competition or training to enhance their performance. Anti-doping tests performed on female athletes in summer Olympic sports from two geographical areas: Australia/ New Zealand, and France were compared. First, the distribution of sample collections across different sports disciplines, as well as the distribution of substances was investigated. Then the distribution of collections and substances detected in the five sports categories (Strength/Speed, Endurance, Mixed, Motor Skills with High Energy Expenditure, and Motor Skills with Low Energy Expenditure) were studied with consideration of therapeutic use exemptions obtained by the athlete. Australia/New Zealand and France were similar in their overall number of anti-doping collections performed. Likewise, both regions had the same sports disciplines (athletics, aquatics, cycling) and sport categories (Mixed and Endurance) as having the highest number of sample collections. The Motor Skills with High Energy Expenditure, and Motor Skills with Low Energy Expenditure categories had the lowest number of sample collections. However, the number of substances detected was significantly different ( < 0.05) with a greater number of substances found in the French data. There were a few substances in common between the two geographical areas, namely prednisone/prednisolone, carboxy-THC, terbutaline, vilanterol and methylphenidate, but most were different. In-competition tests were the category where most of the AAFs were found.

摘要

和任何运动员一样,女性运动员在比赛或训练期间可能会受到诱惑,使用违禁物质来提高成绩。对来自两个地理区域(澳大利亚/新西兰和法国)的夏季奥运会项目的女性运动员进行的反兴奋剂检测进行了比较。首先,调查了不同体育项目的样本采集分布情况以及物质分布情况。然后,考虑到运动员获得的治疗性使用豁免,研究了五个体育类别(力量/速度、耐力、混合、高能量消耗的运动技能和低能量消耗的运动技能)中的采集分布和检测到的物质。澳大利亚/新西兰和法国进行的反兴奋剂采集总数相似。同样,两个地区样本采集数量最多的体育项目(田径、水上运动、自行车)和体育类别(混合和耐力)相同。高能量消耗的运动技能和低能量消耗的运动技能类别样本采集数量最少。然而,检测到的物质数量存在显著差异(<0.05),法国数据中发现的物质数量更多。两个地理区域之间有一些共同的物质,即泼尼松/泼尼松龙、羧基-四氢大麻酚、特布他林、维兰特罗和哌醋甲酯,但大多数物质不同。赛内检测是发现大多数反兴奋剂违规行为的类别。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ab/10515209/e13d0d555d83/fspor-05-1213735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ab/10515209/c6fff63a16d6/fspor-05-1213735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ab/10515209/e13d0d555d83/fspor-05-1213735-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ab/10515209/c6fff63a16d6/fspor-05-1213735-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86ab/10515209/e13d0d555d83/fspor-05-1213735-g002.jpg

相似文献

1
Summer Olympic sports and female athletes: comparison of anti-doping collections and prohibited substances detected in Australia and New Zealand vs. France.夏季奥运会项目与女运动员:澳大利亚和新西兰与法国在反兴奋剂检测样本及检出违禁物质方面的比较
Front Sports Act Living. 2023 Sep 8;5:1213735. doi: 10.3389/fspor.2023.1213735. eCollection 2023.
2
Self-reported attitudes of elite athletes towards doping: differences between type of sport.精英运动员对使用兴奋剂的自我报告态度:不同运动项目之间的差异。
Int J Sports Med. 2006 Oct;27(10):842-6. doi: 10.1055/s-2005-872969. Epub 2006 Feb 1.
3
Urine Caffeine Concentration in Doping Control Samples from 2004 to 2015.2004 年至 2015 年兴奋剂检测尿样中咖啡因浓度。
Nutrients. 2019 Jan 29;11(2):286. doi: 10.3390/nu11020286.
4
Trends in dietary supplement use among athletes selected for doping controls.接受兴奋剂检查的运动员使用膳食补充剂的趋势。
Front Nutr. 2023 Mar 15;10:1143187. doi: 10.3389/fnut.2023.1143187. eCollection 2023.
5
Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017.专项运动中兴奋剂物质的使用:世界反兴奋剂机构 2014 年至 2017 年兴奋剂检测结果分析。
Subst Use Misuse. 2020;55(8):1361-1369. doi: 10.1080/10826084.2020.1741640. Epub 2020 Mar 18.
6
Doping control from a global and national perspective.从全球和国家视角看兴奋剂检查
Ther Drug Monit. 2004 Apr;26(2):171-4. doi: 10.1097/00007691-200404000-00015.
7
Examining pharmacists' anti-doping knowledge and skills in assisting athletes to avoid unintentional use of prohibited substances.检查药师在协助运动员避免无意使用禁用物质方面的反兴奋剂知识和技能。
Int J Pharm Pract. 2023 May 7;31(3):290-297. doi: 10.1093/ijpp/riad015.
8
Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.反兴奋剂教育是否存在近视风险?对奥林匹克球拍运动中物质使用和滥用的比较分析呼吁采取更广泛的方法。
Subst Abuse Treat Prev Policy. 2011 Oct 11;6:27. doi: 10.1186/1747-597X-6-27.
9
World anti-doping regulations for 2005: essential changes for athletes and physicians.《2005年世界反兴奋剂条例》:对运动员和医生的重大变革
Arch Orthop Trauma Surg. 2006 May;126(4):286-8. doi: 10.1007/s00402-005-0043-z. Epub 2005 Dec 6.
10
Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.澳大利亚运动员对世界反兴奋剂机构禁用物质清单和兴奋剂的了解情况。
Int J Drug Policy. 2018 Jun;56:40-45. doi: 10.1016/j.drugpo.2018.02.025. Epub 2018 Mar 15.

本文引用的文献

1
Prevalence of Prohibited Substance Use and Methods by Female Athletes: Evidence of Gender-Related Differences.女运动员违禁药物使用情况及方式:性别相关差异的证据
Front Sports Act Living. 2022 May 24;4:839976. doi: 10.3389/fspor.2022.839976. eCollection 2022.
2
β-Adrenergic agonist salbutamol augments hypertrophy in MHCIIa fibers and sprint mean power output but not muscle force during 11 weeks of resistance training in young men.β-肾上腺素能激动剂沙丁胺醇增强 MHCIIa 纤维的肥大和冲刺平均功率输出,但不能增强年轻男性在 11 周抗阻训练中的肌肉力量。
J Appl Physiol (1985). 2021 Mar 1;130(3):617-626. doi: 10.1152/japplphysiol.00553.2020. Epub 2020 Dec 24.
3
Sport-Specific Use of Doping Substances: Analysis of World Anti-Doping Agency Doping Control Tests between 2014 and 2017.
专项运动中兴奋剂物质的使用:世界反兴奋剂机构 2014 年至 2017 年兴奋剂检测结果分析。
Subst Use Misuse. 2020;55(8):1361-1369. doi: 10.1080/10826084.2020.1741640. Epub 2020 Mar 18.
4
Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK.法国、德国、意大利和英国的哮喘患者口服皮质类固醇处方模式。
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.02363-2019. Print 2020 Jun.
5
Prescription opioid analgesic use in France: Trends and impact on morbidity-mortality.法国处方类阿片类镇痛药的使用情况:趋势及对发病率-死亡率的影响。
Eur J Pain. 2019 Jan;23(1):124-134. doi: 10.1002/ejp.1291. Epub 2018 Aug 20.
6
Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe.过去 10 年法国镇痛药消费趋势及与欧洲各国模式比较。
Br J Clin Pharmacol. 2018 Jun;84(6):1324-1334. doi: 10.1111/bcp.13564. Epub 2018 Apr 2.
7
Effects of erythropoietin abuse on exercise performance.促红细胞生成素滥用对运动表现的影响。
Phys Sportsmed. 2018 Feb;46(1):105-115. doi: 10.1080/00913847.2018.1402663. Epub 2017 Nov 13.
8
Erythropoietin as a performance-enhancing drug: Its mechanistic basis, detection, and potential adverse effects.促红细胞生成素作为一种兴奋剂:其作用机制、检测方法和潜在的不良反应。
Mol Cell Endocrinol. 2018 Mar 15;464:75-87. doi: 10.1016/j.mce.2017.01.033. Epub 2017 Jan 22.
9
Biostatistics Series Module 4: Comparing Groups - Categorical Variables.生物统计学系列模块4:比较组——分类变量。
Indian J Dermatol. 2016 Jul-Aug;61(4):385-92. doi: 10.4103/0019-5154.185700.
10
High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men.高剂量吸入特布他林可增强训练有素男性的肌肉力量并提高最大短跑成绩。
Eur J Appl Physiol. 2014 Dec;114(12):2499-508. doi: 10.1007/s00421-014-2970-2. Epub 2014 Aug 12.